subject: Ibio, Inc. (ibpm) - Financial And Strategic Analysis Review --- Aarkstore Enterprise [print this page] iBio, Inc. (IBPM) - Financial and Strategic Analysis Review
iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefence vaccines, and monoclonal antibodies. iBio is also engaged in the development of novel sub-unit vaccine candidates such as pandemic and seasonal influenza, vaccine candidates for treatment of HPV (human papilloma virus) infections, and vaccine candidates for prevention of anthrax and plague infections. It seeks partnership agreements with other pharma companies for the development of products.
iBio, Inc. Key Recent Developments
Apr 22, 2010: Fraunhofer Centers In Newark, Delaware, And At Boston University Develop Plant-Based Vaccine Factory
Apr 08, 2010: iBio Grants Rights To Use iBioLaunch Platform
Apr 07, 2010: iBio Announces Rights Grant For Anthrax-Plague Combination Vaccine
Apr 01, 2010: iBio Names Pamela Bassett To Board Of Directors
Mar 04, 2010: iBio Names Vidadi Yusibov As Chief Scientific Officer
This comprehensive SWOT profile of iBio, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of iBio, Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
